These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30343982)

  • 1. Contribution of white matter lesions to cognitive decline in Parkinson's disease.
    Grey MT; Veselý B; Gajdoš M; Klobušiaková P; Rektor I
    Parkinsonism Relat Disord; 2019 Apr; 61():248-249. PubMed ID: 30343982
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.
    Crowley SJ; Banan G; Amin M; Tanner JJ; Hizel L; Nguyen P; Brumback B; Rodriguez K; McFarland N; Bowers D; Ding M; Mareci TA; Price CC
    J Parkinsons Dis; 2021; 11(1):283-297. PubMed ID: 33216042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease.
    Ten Harmsen BL; van Rumund A; Aerts MB; Bergkamp MI; Esselink RAJ; Richard E; Meijer FJA; Bloem BR; van Wamelen DJ
    Parkinsonism Relat Disord; 2018 Apr; 49():28-33. PubMed ID: 29306636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic oxidative stress and cognitive function in Parkinson's disease with different PWMH or DWMH lesions.
    Chang TC; Chen YC; Huang YC; Lin WC; Lu CH
    BMC Neurol; 2021 Jan; 21(1):16. PubMed ID: 33430806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease.
    Gera A; Witek N; Bailey M
    Neurology; 2019 Jun; 92(23):1116-1118. PubMed ID: 31160405
    [No Abstract]   [Full Text] [Related]  

  • 9. Episodic memory decline in Parkinson' s disease: relation with white matter hyperintense lesions and influence of quantification method.
    Dunet V; Fartaria MJ; Deverdun J; Le Bars E; Maury F; Castelnovo G; Kober T; Cuadra MB; Geny C; Marechal B; de Champfleur NM
    Brain Imaging Behav; 2019 Jun; 13(3):810-818. PubMed ID: 29948903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease.
    Ngo AB; Smith KM
    J Parkinsons Dis; 2020; 10(4):1695-1698. PubMed ID: 32925096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High baseline perivascular space volume in basal ganglia is associated with attention and executive function decline in Parkinson's disease.
    Foreman RP; Donahue EK; Duran JJ; Schiehser DM; Petkus A; O'Neill J; Holschneider DP; Choupan J; Van Horn JD; Bayram E; Litvan I; Jakowec MW; Petzinger GM
    Brain Behav; 2024 Jul; 14(7):e3607. PubMed ID: 39010690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working Memory Training Responsiveness in Parkinson's Disease Is Not Determined by Cortical Thickness or White Matter Lesions.
    Giehl K; Theis H; Ophey A; Hammes J; Reker P; Eggers C; Fink GR; Kalbe E; van Eimeren T
    J Parkinsons Dis; 2024; 14(2):347-351. PubMed ID: 38277302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.
    Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M
    Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in patients with Parkinson's disease: A 30-month follow-up study.
    Chen L; Yu C; Zhang N; Liu J; Liu W
    Clin Neurol Neurosurg; 2016 Dec; 151():65-69. PubMed ID: 27816027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between White Matter Lesions and Non-Motor Symptoms in Parkinson Disease.
    Lee JY; Kim JS; Jang W; Park J; Oh E; Youn J; Park S; Cho JW
    Neurodegener Dis; 2018; 18(2-3):127-132. PubMed ID: 29870975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence.
    Alzahrani H; Antonini A; Venneri A
    J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.